胰腺实性假乳头状肿瘤454例术后长期生存、生活质量及分子特征
单中心回顾性纳入2001-2021年454例手术切除的胰腺实性假乳头状肿瘤(SPN)患者,长期随访显示预后极佳,术后局部复发或远处转移仅4.1%,近80%患者生活质量未受显著影响,全外显子测序检出CTNNB1等驱动基因突变。
要点
- SPN术后长期生存极佳,即使转移患者预后仍好。
- 保幽门胰十二指肠切除术(PPPD)2-4级并发症最高达32.3%。
- 未发现可可靠预测术后复发或转移的临床病理因素。
核心结论
- SPN患者术后长期生存极佳,即使存在转移;多数患者术后生活质量良好。
研究设计与样本
- 单中心回顾性研究,纳入2001-2021年北京协和医院454例手术切除的SPN患者。
主要发现
- 患者平均年龄31±12岁,男性占18.5%,女性占81.5%,61.3%无症状,肿瘤大小5.38±3.70 cm。
- 组织侵犯、神经侵犯、癌性微血管栓塞、淋巴结转移和远处转移分别占16.5%、2.2%、0.7%、2.0%和3.1%。
- 361例电话问卷受访者中近80%认为术后生活质量未受显著影响,其余20%在术后3-6年随访期间抱怨生活质量下降。
- 全外显子测序在至少2个肿瘤样本中检出28个驱动基因突变,突变频率前3位为CTNNB1、ATRNL1和MUC16。
关键数值与推荐
- 局部切除、远端胰腺切除(伴或不伴脾切除)和胰十二指肠切除(伴或不伴保留幽门)的比例分别为29.7%、28.9%或22.9%、11%或6.8%。
- 保幽门胰十二指肠切除术(PPPD)2-4级并发症发生率最高达32.3%,远端胰腺切除为6.7%(P < 0.001)。
临床怎么用
- SPN术后预后极佳,长期生存好,多数患者生活质量良好,可据此进行术后咨询。
- PPPD术后2-4级并发症发生率较高,需加强围术期管理。
- 目前无可靠临床病理因素预测复发或转移,术后随访策略需综合考虑。
局限性
- 单中心回顾性研究,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To present comprehensive information on the clinicopathological, molecular, survival characteristics, and quality of life (QOL) after surgery for solid pseudopapillary neoplasm (SPN) of the pancreas in a large cohort after long-term follow-up. BACKGROUND: SPN is a rare tumor with an uncertain malignant potential, and solid information on long-term prognosis and QOL remains limited. METHODS: All hospitalized patients with SPNs who underwent surgery between 2001 and 2021 at the Peking Union Medical College Hospital were retrospectively reviewed. The clinicopathological characteristics of the patients were retrieved. A cross-sectional telephone questionnaire was administered to inquire about the QOL. Molecular analyses were performed using whole-exome sequencing. RESULTS: Exactly 454 patients with SPN were enrolled, of whom 18.5% were males and 81.5% were females. The mean patient age was 31 ± 12 years. In total, 61.3% of the patients had no symptoms. The size of the tumors was 5.38 ± 3.70 cm; 83.4% were solid cystic tumors, and 40.1% had calcifications. The proportions of local resection, distal pancreatectomy with or without splenectomy, and pancreaticoduodenectomy with or without pylorus preservation were 29.7%, 28.9% or 22.9%, and 11% or 6.8%, respectively. Over the years, there has been a significant shift from open to minimally invasive surgery. Among all surgical procedures, pylorus-preserving pancreaticoduodenectomy (PPPD) had the highest incidence of grade 2 to 4 complications (up to 32.3%), compared with 6.7% in distal pancreatectomy ( P < 0.001). Regarding histopathology, tissue invasion, perineural invasion, cancerous microvascular emboli, lymph node metastasis, and distant metastasis were present in 16.5%, 2.2%, 0.7%, 2.0%, and 3.1% of patients, respectively. Sixty patients were lost to follow-up. Sixteen of the 390 patients who underwent resection (4.1%) experienced local recurrence or distant metastasis after surgery. In total, 361 patients responded to the telephone survey. Nearly 80% of patients claimed their QOL was not significantly affected after surgery; however, the remaining 20% complained of lower QOL during 3 to 6 years of follow-up after surgery. No clinicopathological factor could reliably predict clinical recurrence or metastasis after resection. A total of 28 driver genes were detected with mutations in at least 2 tumor samples and the top 3 frequently mutated genes were CTNNB1 , ATRNL1 , and MUC16 . CONCLUSIONS: This study presented the largest cohort of patients with SPN after surgery from a single center and reported the QOL of these patients. SPN is associated with extremely favorable long-term survival, even in patients with metastasis, and most patients have a good QOL after surgery.
引用
- Liu Q, Dai M, Guo J, et al. Long-term Survival, Quality of Life, and Molecular Features of the Patients With Solid Pseudopapillary Neoplasm of the Pancreas: A Retrospective Study of 454 Cases. Ann Surg. 2023. PMID: 37036095. doi:10.1097/SLA.0000000000005842
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。